Global Bernie Zeiher, chief medical officer (CMO) of Astellas explains why the ‘patient-defined value’ of medicines is crucial to developing therapies that truly address patients’ unmet medical needs. Zeiher outlines some of Astellas’ work with patient advocacy groups to generate these insights, why a new era of real-world data (RWD) generation…
Asia-Pacific The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L Acquisition; logistics challenges for COVID-19 vaccine distributors; and Moderna’s CMO-based vaccine manufacturing strategy in Asia. Singapore-based Prestige Biopharma prepares for IPO on the Korea Exchange https://www.businesstimes.com.sg/garage/prestige-biopharma-eyes-at-least-18t-won-valuation-in-korean-ipo SINGAPORE-BASED Prestige Biopharma expects an implied market…
Puerto Rico Mayra L Guzman-Kaslow, president and CEO of GK Pharmaceuticals Contract Manufacturing Operations (GK CMO), the first biopharmaceutical company owned by minority woman in the US, highlights the obstacles she and her business partners faced on the way of setting up the company. She also explains why Puerto Rico has been…
Puerto Rico GK CMO, a Puerto Rican contract manufacturing organization (CMO) recently inaugurated its manufacturing facility on the island. With the potential to manufacture advanced biologic and biosimilar products, the event could herald the beginning of a new era for Puerto Rican pharma manufacturing and was thus attended by two of the…
Pharma Manfred Rüdiger (MR), Robbert Van Heekeren (RVH) and Jeroen Rovers (JR), respectively CEO, CFO and CMO of Kiadis Pharma, a Dutch biopharmaceutical company focused on cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders, discuss how the company’s recent IPO will allow them to move forward…
See our Cookie Privacy Policy Here